Demand for Medical Services Dengue Fever Rapid Test Kit Heats Up
April 06 2006 - 1:58PM
PR Newswire (US)
EDMONTON, Alberta, April 6 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
the demand for its VScan Dengue Fever rapid test kit has increased
dramatically. Currently the Company is shipping its Dengue Fever
test kit into 6 different countries and has had requests for
information from another 12 countries. With the start of the
mosquito season in many tropical countries it appears that Dengue
Fever is becoming prevalent throughout the Middle East, Malaysia,
and Southeast Asia. Further based on testing done in the Caribbean
last year, it appears that Dengue Fever is increasing there as
well. Dengue Fever comes in 4 forms. In the mildest form it can
incapacitate an individual for up to 6 months. In the worst form
the individual dies within days through massive hemorrhaging. The
only treatment is fluid replacement therapy which must be started
immediately. Standard laboratories take a minimum of three (3) days
to as long as twenty-one (21) days to complete the testing. Very
few laboratories are even capable of doing the testing for Dengue
Fever. The VScan Dengue Fever test kit gives results in less than
15 minutes and is accurate greater than 99% of the time. The key to
controlling an outbreak of Dengue Fever is early diagnosis. The
VScan Dengue Fever is an excellent tool to be used in this manner.
Based on current orders, plus ongoing negotiations and the requests
for information that the Company is receiving concerning the Dengue
Fever test kits it is reasonable to anticipate that we will sell in
excess of 400,000 Dengue Fever test kits this year which will
generate gross revenue of approximately US $1,200,000. About VScan
The VScan rapid test kit is a single use, disposable, accurate,
cost effective, easy to use, test for the screening of HIV 1&2,
Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile,
Syphilis, Malaria, and Prostate Cancer. The kits cannot be sold in
Canada. Medical Services International Inc trades in the United
States on the NQB Pinksheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright